Call Schedule & Guidance

Applications for the User Engagement & Partnership Development, Secondment and Pathfinder & Feasibility activity strands should be developed in collaboration with your local Research & Innovation Development Manager/ Officer, or an equivalent Research & Innovation Professional.

They will be able to assist with developing your idea, engaging with appropriate external partners and identifying tangible economic and/or societal impacts.

All User Engagement & Partnership Development and Secondment applications must be submitted with a letter of support from the external partner.

Proof of Market and Proof of Concept applications should be prepared with assistance from the Commercialisation Team. To discuss eligibility and the application process for Commercialisation applications, please contact

Project costings must be prepared in conjunction with your Faculty Research & Innovation Office.

2022/23 Call Schedule

Wednesday 11th May 2022

  • User Engagement & Partnership Development – Lead funder EPSRC/STFC only
  • People Mobility: Secondment – Lead funder EPSRC/STFC only
  • Pathfinder & Feasibility – Lead funder Wellcome Trust or MRC only
  • Proof of Concept – All funders

Wednesday 7th September 2022

  • All strands and all funders (excl. PGR Placement)

Wednesday 9th November 2022

  • All strands and all funders (excl. PGR Placement)

Wednesday 8th February 2023

  • All strands and all funders (excl. PGR Placement)

Award notifications will be sent two/three weeks after the call deadline.

Additionally, ad hoc applications up to the following values may be considered outside of the call cycle, however if their submission coincides with an imminent call deadline it is likely that they will be considered as part of that call:

  • Proof of Market up to £15k
  • Pathfinder & Feasibility: User Need / Commercial Evaluations up to £10k
  • Applications up to £5k (excludes PGR Placements)

To submit an application, please email a signed electronic copy of the completed application form to the Translational Research Portfolio Team.